Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07227883 · ClinicalTrials.gov registry record · Early Phase 1
Secretome Treatment for Facial Rejuvenation
A Early Phase 1 study of Stem Cell and Rejuvenation, sponsored by Acorn Biolabs.
- Recruiting
- Registry status
- Early Phase 1
- Development phase
- 24
- Enrollment target
- 1
- Study location
NCT07227883 is a Early Phase 1 study of Stem Cell and Rejuvenation that is actively recruiting participants, run by Acorn Biolabs. The registered enrollment target is 24 participants. The trial reports 1 study location across 1 state.
The verdict
NCT07227883, a Early Phase 1 study of Stem Cell and Rejuvenation, is actively recruiting participants, sponsored by Acorn Biolabs.
- RECRUITING
- Registry status
- Early Phase 1
- Development phase
- 24 participants
- Enrollment target
- 1
- Study location
Study Summary
Secretome treatment for facial rejuvenation
Conditions Studied
Interventions
- OTHER Autologous Hair Follicle-Derived Secretome
- OTHER Control Saline
Study Locations (1)
California
- Steve Yoelin, MD - Newport Beach
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2025-12-15 |
| Est. Completion | 2026-12-20 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07227883
The ClinicalTrials.gov registry entry for NCT07227883 describes a study currently listed as recruiting, categorized as Early Phase 1. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Acorn Biolabs, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 4 conditions, with Stem Cell appearing as the primary indexed condition, and to 2 interventions - of which Autologous Hair Follicle-Derived Secretome is the first listed.
NCT07227883 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT07227883 about?
NCT07227883 is a clinical study titled "Secretome Treatment for Facial Rejuvenation". Secretome treatment for facial rejuvenation
What is the current status of trial NCT07227883?
This trial is currently recruiting. It is a Early Phase 1 study. The enrollment target is 24 participants. The study started on 2025-12-15. Estimated completion is 2026-12-20.
What conditions does trial NCT07227883 study?
This clinical trial studies the following conditions: Stem Cell, Rejuvenation, Facial Aging, Stem Cell Banking.
What interventions are being tested in trial NCT07227883?
The interventions under investigation include: Autologous Hair Follicle-Derived Secretome (OTHER), Control Saline (OTHER).
Who is sponsoring clinical trial NCT07227883?
This trial is sponsored by Acorn Biolabs, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07227883 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Stem Cell
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.